相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: Characterization of interaction of NSAIDs with phosphatidylcholine
Lenard M. Lichtenberger et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Non-Steroidal Anti-Inflammatory Drugs and Gastroprotection with Proton Pump Inhibitors A Focus on Ketoprofen/Omeprazole
Antonio Gigante et al.
CLINICAL DRUG INVESTIGATION (2012)
Prodrugs of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), More Than Meets the Eye: A Critical Review
Amjad M. Qandil
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Pharmacological Evaluation and Preliminary Pharmacokinetics Studies of a New Diclofenac Prodrug without Gastric Ulceration Effect
Jean Leandro dos Santos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Investigation of anticholinergic and non-steroidal anti-inflammatory prodrugs which reduce chemically induced skin inflammation
Sherri C. Young et al.
JOURNAL OF APPLIED TOXICOLOGY (2012)
Effect of the Clopidogrel-Proton Pump Inhibitor Drug Interaction on Adverse Cardiovascular Events in Patients with Acute Coronary Syndrome
Sharvari M. Bhurke et al.
PHARMACOTHERAPY (2012)
Design, synthesis and biological evaluation of brain-specific glucosyl thiamine disulfide prodrugs of naproxen
Wei Fan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
Neena S. Abraham et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Structural and binding studies of C-terminal half (C-lobe) of lactoferrin protein with COX-2-specific non-steroidal anti-inflammatory drugs (NSAIDs)
Rafia Mir et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Omeprazole and clopidogrel: Should clinicians be worried?
Jeremiah P. Depta et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2010)
Clopidogrel with or without Omeprazole in Coronary Artery Disease.
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Guidelines for Prevention of NSAID-Related Ulcer Complications
Frank L. Lanza et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: Synthesis, biological evaluation and nitric oxide release studies
Khaled R. A. Abdellatif et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
The Structural Basis for the Prevention of Nonsteroidal Antiinflammatory Drug-Induced Gastrointestinal Tract Damage by the C-Lobe of Bovine Colostrum Lactoferrin
Rafia Mir et al.
BIOPHYSICAL JOURNAL (2009)
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
David N. Juurlink et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2009)
Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
P. Michael Ho et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Rescue strategies against non-steroidal anti-inflammatory drug-induced gastroduodenal damage
Yun Jeong Lim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Medicinal Chemistry and Anti-Inflammatory Activity of Nitric Oxide-Releasing NSAI Drugs
Esra Koc et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
Michelle L. O'Donoghue et al.
LANCET (2009)
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
Deepak L. Bhatt et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin
Martine Gilard et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Role of Dose Potency in the Prediction of Risk of Myocardial Infarction Associated With Nonsteroidal Anti-Inflammatory Drugs in the General Population
Luis Alberto Garcia Rodriguez et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial
John A. Baron et al.
LANCET (2008)
Hydrogen sulfide-releasing anti-inflammatory drugs
John L. Wallace
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Activity and potential role of licofelone in the management of osteoarthritis
Arrigo F. G. Cicero et al.
CLINICAL INTERVENTIONS IN AGING (2007)
Licofelone-A novel analgesic and anti-inflammatory agent
S. K. Kulkarni et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin
M. Gilard et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The role of cyclooxygenase in gastric mucosal protection
K Gudis et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
The third gas:: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis
S Fiorucci et al.
HEPATOLOGY (2005)
Licofelone, a novel 5-LOX/COX-inhibitor, attenuates leukocyte rolling and adhesion on endothelium under flow
H Ulbrich et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Recombinant human lactoferrin prevents NSAID-induced intestinal bleeding in rodents
EJ Dial et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2005)
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
DL Bhatt et al.
AMERICAN HEART JOURNAL (2004)
Membrane permeabilization by non-steroidal anti-inflammatory drugs
W Tomisato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The metabolic effects of inhibitors of 5-lipoxygenase and of cyclooxygenase 1 and 2 are an advancement in the efficacy and safety of anti-inflammatory therapy
F Celotti et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2003)
Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs
J Martel-Pelletier et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical
K Biswas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
NSAIDs, gastroprotection and cyclo-oxygenase-II-selective inhibitors
R Micklewright et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Recombinant human lactoferrin ingestion attenuates indomethacin-induced enteropathy in vivo in healthy volunteers
FJ Troost et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2003)
Esomeprazole 40 mg provides improved intragastric acid control as compared with lansoprazole 30 mg and rabeprazole 20 mg in healthy volunteers
CH Wilder-Smith et al.
DIGESTION (2003)
Lansoprazole fast disintegrating tablet: A new formulation for an established proton pump inhibitor
F Baldi et al.
DIGESTION (2003)
Dual COX inhibition and upper gastrointestinal damage
MM Skelly et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis
FKL Chan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Structure and stereochemistry of the active metabolite of clopidogrel
JM Pereillo et al.
DRUG METABOLISM AND DISPOSITION (2002)
Pharmacology and potential therapeutic applications of nitric oxide-releasing non-steroidal anti-inflammatory and related nitric oxide-donating drugs
JE Keeble et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
The mechanism of action of the new antiinflammatory compound ML3000: inhibition of 5-LOX and COX-1/2
S Tries et al.
INFLAMMATION RESEARCH (2002)
Risk of cardiovascular events associated with selective COX-2 inhibitors
D Mukherjee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries
JK Hennan et al.
CIRCULATION (2001)
Lack of gastric toxicity of nitric oxide-releasing indomethacin, NCX-530, in experimental animals
K Takeuchi et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability
RJ Playford et al.
CLINICAL SCIENCE (2001)
Effects of diclofenac in the rat tail ischaemia-reperfusion injury model of acute hyperalgesia
RF Grace et al.
PAIN (2001)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial
PJ Kahrilas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial
FE Silverstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Nitric oxide in mucosal defense: A little goes a long way
JL Wallace et al.
GASTROENTEROLOGY (2000)
Nonsteroidal anti-inflammatory drug gastropathy
CJ Hawkey
GASTROENTEROLOGY (2000)
NO-naproxen modulates inflammation, nociception and downregulates T cell response in rat Freund's adjuvant arthritis
C Cicala et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Long-term omeprazole treatment in resistant gastroesophageal reflux disease:: Efficacy, safety, and influence on gastric mucosa
EC Klinkenberg-Knol et al.
GASTROENTEROLOGY (2000)
分享论文
